Kerafast

10 unique reagents that helped advance research in 2016

At Kerafast, our mission is to facilitate access to unique reagents developed by academic researchers. Together with our providing investigators, we get one-of-a-kind bioreagents into the hands of scientists worldwide who can use the materials to accelerate their own research. As we begin 2017, we took the opportunity to review how reagents in our catalog 

Continue Reading…

How killer T cells control Zika infection

Zika, a virus transmitted primarily by Aedes mosquitoes, became a significant global health concern last year. The threat emerged in Brazil and quickly spread to other parts of the world, causing microencephaly and other birth defects in babies born to infected mothers, as well as rare neurological conditions in adults. Although Zika has faded from 

Continue Reading…

Scientists Identify TRAP1 as Key Driver of Prostate Cancer

About 1 in 7 men will be diagnosed with prostate cancer in their lifetimes, according to the American Cancer Society, making it the second-most common form of cancer in American men. Recently, a potentially promising new therapeutic target for the disease was identified by scientists from The Wistar Institute, one of Kerafast’s providing institutions. The 

Continue Reading…

New markers to assess Huntington’s disease progression

Huntington’s disease is a debilitating, progressive disease that is eventually fatal. Affecting nerves of the brain, Huntington’s disease (HD) deteriorates an individual’s mental and physical capabilities over time. A recent study published in The Journal of Experimental Medicine by Stanford University researchers identified potential biomarkers to assess disease progression and analyze treatment effectiveness. Huntington’s disease 

Continue Reading…

How the microbiota influences Crohn’s disease

Crohn’s disease (CD) is an inflammatory bowel disease that causes chronic inflammation of the gastrointestinal tract, most commonly in the small intestine. It is estimated that more than a half million people in the United States suffer from CD. The most common symptoms of Crohn’s disease include diarrhea, abdominal cramping and weight loss. The complications 

Continue Reading…

Intro to Plasmids and Vectors

Here at Kerafast, our portfolio of available plasmids continues to grow; in recent months, for example, we’ve added Wnt pathway plasmids from the University of Rochester, hepatitis B virus expression plasmids from Penn State College of Medicine and human Bcl-xL plasmids from the University of Louisville. We thought we’d take this opportunity to review what 

Continue Reading…